other material
confidence high
sentiment neutral
materiality 0.45
Viridian shareholders approve 2M share increase for equity plan; directors elected
Viridian Therapeutics, Inc.\DE
- Amendment to 2016 equity plan approved (32.2M for, 24.3M against), adding 2M shares to reserve.
- Class III directors Stephen Mahoney and Arlene M. Morris elected; Morris received 24.9M withheld votes.
- Advisory vote on exec compensation passed: 32.8M for, 23.7M against.
- Ratification of KPMG as independent auditor passed: 58.4M for, 31.7K against.